The UNM Comprehensive Cancer Center is the Official Cancer Center of New Mexico and the only National Cancer Institute-designated Comprehensive Cancer Center in the state.
The UNM Comprehensive Cancer Center is the Official Cancer Center of New Mexico and the only National Cancer Institute-designated Comprehensive Cancer Center in the state.
1 From Memorial Sloan Kettering Cancer Center; Robert H. Lurie Comprehensive Cancer Center of Northwestern University; The University of Texas MD Anderson Cancer Center; Massachusetts General Hospital Cancer Center; Stanford Cancer Institute; UCSF Helen Diller Family Comprehensive Cancer Center; Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School of Medicine; The Ohio State University Comprehensive Cancer Center - James Cancer Hospital and Solove Research Institute; Fox Chase Cancer Center; Huntsman Cancer Institute at the University of Utah; Mayo Clinic Cancer Center; Roswell Park Cancer Institute; University of Michigan Comprehensive Cancer Center; Duke Cancer Institute; Consultant; Dana-Farber/Brigham and Womens Cancer Center; Fred & Pamela Buffett Cancer Center; City of Hope Comprehensive Cancer Center; Fred Hutchinson Cancer Research Center/Seattle Cancer Care Alliance; University of Colorado Cancer Center; Vanderbilt-Ingram Cancer Center; UC San Diego Moores ...
The UNM Comprehensive Cancer Center is the Official Cancer Center of New Mexico and the only National Cancer Institute-designated Comprehensive Cancer Center in the state.
Fox Chase Cancer Center is a National Cancer Institute-designated Comprehensive Cancer Center research facility and hospital located in the Fox Chase section of Philadelphia, Pennsylvania, United States. The main facilities of the center are located on property adjoining Burholme Park. The center is part of the Temple University Health System (TUHS) and specializes in the treatment and prevention of cancer. The center was formed in 1974 by the merger of the American Oncologic Hospital, which was founded in 1904 as the first cancer hospital in the United States, and the Institute for Cancer Research, founded in 1927. The center was an independent, non-profit institution until it became part of TUHS July 1, 2012. Today it has almost 2,400 employees and an operating budget of $300 million. Research is conducted in more than 80 laboratories by a staff of more than 325 physicians and scientists who hold medical degrees, Ph.D.s or both. Fox Chases 100-bed hospital is one of the few facilities in the ...
WHO: Moffitt Cancer Center, the only National Cancer Institute-designated Comprehensive Cancer Center based in Florida, will host Lymphoma Treatment Today and the Research Outlook for Tomorrow, a free educational event in collaboration with the Leukemia & Lymphoma Society®.. WHAT: The free educational event will feature Moffitt experts discussing the latest recommendations for treatment and promising research outlooks for Lymphoma. Attendees will have an opportunity ask questions during several breakout sessions.. WHEN: Thursday, Jan. 16, 2014, 4:30 - 8:30 p.m.. WHERE: Moffitt Cancer Center, 12902 Magnolia Drive, Stabile Research Building, Tampa, Fla. 33612. CONTACT: Pre-registration is required. Please call 813-963-6461, ext. 1798.. About Moffitt Cancer Center. Located in Tampa, Moffitt is one of only 41 National Cancer Institute-designated Comprehensive Cancer Centers, a distinction that recognizes Moffitts excellence in research, its contributions to clinical trials, prevention and cancer ...
Birrer comes to UAB from Massachusetts General Hospital, where he is director of Medical Gynecologic Oncology and director of the Gynecologic Cancer Research Program at the Gillette Cancer Center. He also serves as the leader of the Dana Farber/Harvard Cancer Center program in gynecologic cancers and is a professor of medicine at Harvard Medical School.. Birrer will succeed Edward E. Partridge, M.D., the Evalina B. Spencer Chair in Oncology, who is retiring from UAB after a remarkable 48-year career, including 10 years as director of the Comprehensive Cancer Center. Birrer will join UAB on Aug. 1.. "Mike Birrer is an outstanding physician-scientist who balances a vision of transformation and leadership," said Selwyn M. Vickers, M.D., FACS, senior vice president for Medicine and dean of the School of Medicine. "He understands drivers for excellence in clinical care and has a vision for growing precision medicine in cancer care, as well as a well-established commitment to fundamental scientific ...
Get cancer facts, patient care numbers, updates on cancer clinical care, cancer support services, cancer research programs and learn about our community outreach efforts - as well as meet the U-M Comprehensive Cancer Center leadership.
Michelle M. Le Beau, PhD, Arthur and Marian Edelstein Professor of Medicine, was appointed director of the University of Chicago Medicine Comprehensive Cancer Center in April 2004. Dr. Le Beau is particularly well qualified to enhance translational and interdisciplinary research at the Comprehensive Cancer Center, in view of her impressive record of converting fundamental laboratory findings into highly relevant advances in the diagnosis and treatment of patients with hematological malignant diseases.. Dr. Le Beau received her PhD in pathology and genetics in 1981 at the University of Illinois. She subsequently obtained post-doctoral training at The University of Chicago Medicine under the mentorship of Janet D. Rowley, MD, DSc, the Blum-Riese Distinguished Service Professor of Medicine, and was appointed to the faculty in 1986, rising to tenured professor in 1997. In her capacity as director of the Cancer Cytogenetics Laboratory, Dr. Le Beau directs a cancer diagnostics laboratory, which ...
...UCSF Comprehensive Cancer Center basic scientists and clinical resear...The $11.9 million five-year grant with an additional $12 million in ...The so-called SPORE grant for Specialized Program of Research Excell... Our goal with this SPORE is to take a fresh approach to trying to so...,UCSF,Comprehensive,Cancer,Center,program,triumphs,biological,biology news articles,biology news today,latest biology news,current biology news,biology newsletters
Dr. Chiung-Yu Huang is Professor of Biostatistics at the Department of Epidemiology and Biostatistics and an elected Fellow of the American Statistical Association (ASA). She is a Member of the UCSF Helen Diller Family Comprehensive Cancer Center and an Adjunct Professor at the Johns Hopkins University Sidney Kimmel Comprehensive Cancer Center. She is recognized for her novel methodology research in survival analysis, competing risks analysis, recurrent event analysis, outcome-dependent sampling, and design and evaluation of vaccine efficacy trials. Dr. Huangs recent methodology contributions include (1) methods for combining information from external large databases, such as disease registries, to improve efficiency in the analysis of relatively small-scale studies that collect more detailed patient-level information. The importance of such methods has been recognized as we have now entered the big bata era; (2) methods to better model, estimate, and predict the risk of recurrent events to ...
Background: Vascular endothelial growth factor (VEGF) inhibitors disrupt angiogenesis and slow tumor growth but have a clinically significant side effect of hypertension. Between 9-59% of patients may develop hypertension induced VEGF inhibitors. Medication labeling for VEGF inhibitors recommend standard pharmacologic treatment of hypertension, interruption of chemotherapy, or discontinuation during hypertensive crisis. Actively controlling patients blood pressure allows them to receive the optimal dose of antineoplastic agent without the complication of hypertension. The purpose of this study is to evaluate an institutions practices of monitoring, identifying, and treating patients VEGF inhibitor induced hypertension. Methods: This retrospective, single-center, chart review assessed patients blood pressure measurements who received bevacizumab, ramucirumab, sorafenib, regorafenib, sunitinib, or pazopanib. Patients were excluded if they were less than 18, received VEGF inhibitors for ...
Men with advanced prostate cancer can now receive a new innovative treatment in the Sarah Bush Lincoln Regional Cancer Center. SBL is the only cancer center in the region to offer Xofigo® , a new type of targeted radiation therapy.. In May, the U.S. Food and Drug Administration (FDA) approved Xofigo® (radium 223 dichloride) to treat men with symptomatic late-stage (metastatic) castration-resistant prostate cancer that has spread to bones, but not to other organs. It is intended for men whose cancer has spread after receiving medical or surgical therapy to lower testosterone.. "Xofigo® is an important new treatment added to our robust nuclear therapeutics program," said Abdur R Shakir, MD, SBL Regional Cancer Center Medical Director. "While we provide the people of East Central Illinois with leading-edge treatments for a broad range of cancers, we are proud to play a significant role in the development and delivery of important new breakthrough treatments as part of the Regional Cancer ...
Recognizing a critical need to improve national vaccination rates for the human papillomavirus (HPV), the UAB Comprehensive Cancer Center has again united with each of the 69 National Cancer Institute (NCI)-designated cancer centers in issuing a joint statement in support of recently revised recommendations from the Centers for Disease Control and Prevention (CDC).. According to the CDC, incidence rates of HPV-associated cancers have continued to rise, with approximately 39,000 new HPV-associated cancers now diagnosed each year in the United States. Although HPV vaccines can prevent the majority of cervical, anal, oropharyngeal (middle throat) and other genital cancers, vaccination rates remain low across the U.S., with just 41.9 percent of girls and 28.1 percent of boys completing the recommend vaccine series.. The new guidelines from the CDC recommend that children aged 11 to 12 should receive two doses of the HPV vaccine at least six months apart. Adolescents and young adults older than 15 ...
Marnie Livingston, Tammy Welden and Abbey DeGraffenreid. Posted May 8, 2013. Marnie Livingston is grateful that her breast cancer was caught early and treated successfully. Tammy Welden is appreciative for her sons renewed health after an accident left him near death. Abbey DeGraffenreid is thankful that she no longer has signs of lymphoma. And Terri Wolf is glad for her secure job as an oncology nurse.. They are among a growing number of UC Davis Health System employees who invest in community health by supporting the UC Davis Comprehensive Cancer Center.. Livingston, an executive assistant, is donating $5,000 to the cancer centers expansion project to honor her surgical oncologist, James Goodnight.. "I am donating because I want to make sure that other people can get the kind of care that I received," says Livingston.. Abbey DeGraffenreid, who works in perioperative services, is donating $5,000 to honor Goodnight, $2,500 to name an infusion chair and $2,500 to lymphoma research.. "I hope to ...
A listing of the available patient education materials covering pancreatic cancer, pancreatic cysts and other diseases of the pancreas developed by the Pancreatic Cancer Clinic at the University of Michigan Comprehensive Cancer Center.
UNC Lineberger Comprehensive Cancer Centers leadership, program directors, communications and development staff, and N.C. Cancer Hospital administration
The Holden Comprehensive Cancer Center at the University of Iowa Hospitals & Clinics in Iowa City, Iowa is home to a lung cancer clinic where mesothelioma and other lung diseases are treated.
The UC Davis Comprehensive Cancer Center will host a Tweet chat to discuss the latest approaches to lung cancer treatment on Nov. 27 at 1 p.m. in recognition of Lung Cancer Awareness Month. Twitter users are invited to log in and join the conversation about new medical, surgical and radiation oncology approaches to the disease from cancer center experts. To join, follow #UCDcancerchat.
The mission of the Comprehensive Cancer Center is "to elucidate the determinants of cancer, to develop cures for cancer and to prevent cancer through innovation and collaboration.". Members are expected to contribute to this overriding objective through a broad range of clinical and research activities including:. ...
The Robert H. Lurie Comprehensive Cancer Center of Northwestern University is an NCI-designated, university based, matrix cancer center conducting a broad range...
Case Western Reserve University Case Comprehensive Cancer Center is a top cancer clinic where leading mesothelioma doctors employ the latest treatment methods to help cancer patients.
The expansion of knowledge in the area of cancer biology which has taken place over the last 40 years has profoundly influenced clinical cancer research and made high-quality multidisciplinary cancer care imperative. In the United States, Comprehensive Cancer Centres (CCCs) have existed for a long time. To enhance their effectiveness and quality, the National Cancer Institute (NCI) has developed an accreditation methodology for CCCs [1]. NCI-designated CCCs are characterised by innovative high-quality cancer research covering the complete trajectory-from basic to clinical research, as well as dissemination of acquired knowledge.. ...
This training program is available to allied health care professionals and medical staff. It provides candidates with the appropriate training to fully operate a functional scientific oncology core facility at their home institution or hospital. The training will be provided at Roswell Park Comprehensive Cancer Center under the supervision of a core director and appropriate Roswell Park staff.
The Cancer Pain Management Service (CPMS) at Roswell Park Comprehensive Cancer Center uses a team approach to reducing pain in cancer patients. The expertise of anesthesiologists, psychologists, nurses, acupuncturists, physical and occupational therapists, nutritionists, and social workers merges into a comprehensive pain management plan designed to meet the individual needs of each patient. The first step is to assess the patients level of pain from the information provided on the Comprehensive Pain Assessment Questionnaire.
To advance knowledge, identify the most effective care and help future patients, the Edwards Comprehensive Cancer Center maintains an active clinical trials program and maintains a listing of the clinical trials that are currently available.. If you have questions about whether a clinical trial is an option for you, please contact Barbara Payne, RN, OCN, CCRP, Clinical Research Supervisor. For more information about Pediatric Clinical Trials, please contact Teresa Giles at 304.399.6653.. ...
UCLA scientists have unlocked an important mechanism that allows chemotherapy-carrying nanoparticles-extremely small objects between 1 and 100 nanometers (a billionth of a meter)-to directly access pancreatic cancer tumors, thereby improving the ability to kill cancer cells and hence leading to more effective treatment outcome of the disease. The researchers also confirmed the key role of a peptide (an extremely small protein) in regulating vascular access of the nanoparticle to the cancer site.. The discovery is the result of a two-year study co-led by Drs. Huan Meng and André Nel, members of UCLAs Jonsson Comprehensive Cancer Center and the UCLA California NanoSystems Institute. The findings are important as they demonstrate how the delivery of chemotherapy to pancreatic cancer can be improved significantly through the use of smart-designed nanoparticle features.. Pancreatic ductal adenocarcinoma is generally a fatal disease, with a five-year survival rate of less than 6 percent. The ...
CHAPEL HILL, N.C. - John Boggess, MD, associate professor of obstetrics and gynecology, was honored with a Health Care Heroes Award by the Triangle Business Journal. His Health Care Innovator/Researcher Award was given in recognition of his pioneering work with robotic surgery for gynecologic cancers. Boggess is a member of UNC Lineberger Comprehensive Cancer Center.. Due in large part to his training of other surgeons, robotic surgery is now the number one treatment for gynecologic cancer in the US, according to an executive with Intuitive Surgical, Inc. Boggess has presented the surgical techniques at national and international meetings and has hosted training visits to UNC for over 400 gynecologic oncology specialists.. The greatest significance of Boggess efforts is the impact robotic-assisted surgery has for patients. He has published reports in professional journals demonstrating that robotic-assisted surgery decreases complications, blood loss, pain and recovery time without compromising ...
The Herbert Irving Comprehensive Cancer Center at NewYork-Presbyterian / Columbia University Irving Medical Center is conducting hundreds of clinical trials to improve care for many types of conditions.. Use the tool below to find our clinical trials that are currently enrolling new patients. Each listing explains the purpose of the trial, links to the investigators biography, the trials eligibility criteria, and how to get more information.. ...
The Herbert Irving Comprehensive Cancer Center at NewYork-Presbyterian / Columbia University Irving Medical Center is conducting hundreds of clinical trials to improve care for many types of conditions.. Use the tool below to find our clinical trials that are currently enrolling new patients. Each listing explains the purpose of the trial, links to the investigators biography, the trials eligibility criteria, and how to get more information.. ...
The Comprehensive Cancer Center of Wake Forest University has selected three types of cancer on which to focus major research efforts and expertise: brain tumors, breast cancer, and prostate cancer.
UCLAs Jonsson Comprehensive Cancer Center. Get information on prostate cancer risk factors, prevention, symptoms, diagnosis, treatment and more.
Sylvester Comprehensive Cancer Center is South Floridas leader in cancer diagnosis and provides state-of-the-art treatment as well as follow-up care.
Sylvester Comprehensive Cancer Center is South Floridas leader in cancer diagnosis and provides state-of-the-art treatment as well as follow-up care.
While tobacco use is the single largest preventable cause of disease and premature death in the United States, smoking has become far less prevalent in the country in recent years, in part because of anti-tobacco campaigns and a general push toward better health, says Stanton A. Glantz, PhD, director of the Center for Tobacco Control Research and Education. The centers faculty members are affiliated with the UCSF Helen Diller Family Comprehensive Cancer Center.. "Currently, in California, about 12 percent of the population smokes, Glantz says, "with two-thirds of them being light smokers.. For social smokers as well as heavy smokers, it can be a daunting challenge to halt an entrenched addiction. Some are afraid to stop - theyve smoked so long. Some are ashamed to reach out for help until theyre sick. And some simply believe they can quit whenever they like.. At their disposal awaits a battery of possible remedies: nicotine replacement patches and gum, nicotine inhalers, antidepressants, ...
At the University of Chicago Comprehensive Cancer Center patients can benefit from the experience of staff for excellent mesothelioma care.
My research interests are focused on understanding how protein interactions and trafficking events, within the overall cell architecture, are related to pathogenic mechanisms in cancer. During the past few years, I have been able to build on my solid background in molecular and cellular biology by acquiring skills in state-of-the-art biochemical and imaging techniques. One of my two main scientific foci is on the high affinity receptor for IgE, the FcεRI, and its implication in allergies, asthma and mast cell diseases. I am applying my unique skill set to the dissection of FcεRI signal initiation and the spatiotemporal coordination of endocytic trafficking by signaling and adaptor proteins. My second area of research aims at uncovering the underlying mechanisms of the myeloproliferative neoplasms (MPNs) pathogenesis. I am characterizing the complex interplay between Jak2, Mpl and calreticulin, the three main players in MPNs, and their altered trafficking-related signaling properties. My ...
Centro de investigación integral en cáncer según el modelo Comprehensive Cancer Center, adscrito al CSIC (Centro Superior de Investigaciones Científicas) y la Universidad de Salamanca, el CIC de Salamanca desarrolla principalmente programas de investigación y formación en ciencia biomédica básica y aplicada
Liver cancer information: signs and symptoms, diagnosis, treatment, your team, and support from UC Davis Comprehensive Cancer Center.
2018 UCLA Jonsson Comprehensive Cancer Center. All Rights Reserved. , Website Created By Vision Internet - Innovators of Online Government. ...
Mat-Su Valley Comprehensive Cancer Center Is Your Provider For Treatment & Relief From Cancer In & Around Palmer, AK. Call Us Today To Start Your Fight!
The UAB Comprehensive Cancer Center has received a prominent national Innovator Award from the Association of Community Cancer Centers (ACCC) for its Patient Care Connect Program. The award is given only to ACCC members that are forward-thinking in creating replicable solutions to improve access, quality and value of patient care ...
The UAB Comprehensive Cancer Center has received a prominent national Innovator Award from the Association of Community Cancer Centers (ACCC) for its Patient Care Connect Program. The award is given only to ACCC members that are forward-thinking in creating replicable solutions to improve access, quality and value of patient care ...
The Association of Community Cancer Centers (ACCC) has launched the Institute for Clinical Immuno-Oncology (ICLIO) in order to promote the advancement of access to immuno-oncology therapies, particularly in the community care setting.. To facilitate the adoption of immuno-oncology in the community cancer setting, ICLIO will educate medical professionals on the best practices for integrating immuno-oncology into clinical care, insurance and reimbursement, social work, and patient access to novel treatment options.. Resources for the multidisciplinary team include a monthly e-newsletter, monthly e-courses, the ICLIO Scholars Program, the ICLIO White Paper, and the ICLIO National Education Conference.. RELATED: Immunotherapies Shine at ASCO Annual Meeting. Providers with membership to ACCC, who are estimated to treat over 60% of all patients with cancer, will also have access to ICLIO. ICLIO is chaired by Lee S. Schwartzberg, MD, FACP, Chief of the Division of Hematology and Oncology at The West ...
Authors Affiliations: 1Complutense University and Hospital General Universitario Gregorio Maranon, Servicio De Oncologia Medica, Madrid, Spain; 2Andrew Love Cancer Centre, Barwon Health, Geelong, Victoria, Australia; 3Clinique Victor Hugo-Centre Jean Bernard, Cedex 2, France; 4University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania; 5Onkologische Schwerpunktpraxis, Mannheim, Germany; 6Institutul Oncologic Ion Chiricuta, Cluj-Napoca, Romania; 7Cancer Research UK, University of Sussex, Falmer, Brighton, United Kingdom; 8National Cancer Center Hospital, Tokyo, Japan; 9Medical University of Gdansk, Gdańsk, Poland; 10Tom Baker Cancer Centre, Calgary, Alberta, Canada; 11Beatson Oncology Centre, Glasgow, Scotland, United Kingdom; 12Allgemeines Krankenhaus St. Georg, Clinical Division of Oncology, Waehringer Guertel, Vienna, Austria; 13Arizona Cancer Center, University of Arizona, Tucson, Arizona; 14Sylvester Comprehensive Cancer Center at Deerfield, Deerfield Beach, Florida; and Departments ...
DAYTONA BEACH, Fla., July 25, 2017 - Florida Hospital Memorial Medical Center has been designated as one of seven national testing sites for the Association of Community Cancer Centers (ACCC) project to improve care for Medicaid patients with lung cancer.
The UPMC Vision and Rehabilitation Hospital, on the UPMC Mercy campus, is expected to open in 2020 to offer advanced clinical vision care. Clinicians and researchers at the new hospital will pursue promising new research for vision restoration and diseases of the eye, and offer technology-assisted rehabilitation services that restore mobility for patients with wide-ranging physical and cognitive challenges.The all-new hospitals will be situated on the campuses of UPMCs Mercy, Presbyterian and Shadyside hospitals. Designs for the UPMC Heart and Transplant Hospital and the UPMC Hillman Cancer Hospital will be selected in an international design competition.. Patients of the UPMC Hillman Cancer Center, a name that is synonymous with unmatched excellence in cancer care, and the only National Cancer Institute-designated Comprehensive Cancer Center in the region, will receive specialized treatment in the new UPMC Hillman Cancer Hospital, located on the UPMC Shadyside campus. The facility is expected ...
Dr. Timmerman, holder of the Effie Marie Cain Distinguished Chair in Cancer Therapy Research, is a member of UT Southwesterns Harold C. Simmons Comprehensive Cancer Center, the only National Cancer Institute-designated cancer center in North Texas and a National Clinical Trials Network Lead Academic Site.. This Phase 2 clinical trial involved 24 patients with stage 4 non-small cell lung cancer (NSCLC) whose cancer has continued to spread during their initial therapy. Such patients typically have poor survival rates, and SBRT is not typically used in these patients, said first author Dr. Puneeth Iyengar, Assistant Professor and Director of Clinical Research of Radiation Oncology, and co-leader of the Simmons Cancer Center Thoracic Oncology Group.. The revolutionary SBRT technique is a type of radiation therapy in which a few very high doses of radiation are delivered from multiple angles to small, well-defined tumors. The goal is to deliver a radiation dose high enough to kill the cancer, while ...
Department Of Radiotherapy, Regional Cancer Centre, Pgimer, Chandigarh is an ESMO Designated Centre of Integrated Oncology and Palliative Care
Regional Cancer Centre (RCC) of the centrally funded premier medical institution JIPMER planned to hold camps in villages to create awareness on various methods for early detection of cancer.